Sales reached €23.77 billion, up 6.5%[1] versus the same period last year, significantly outperforming the global beauty market. E-commerce continued to grow at a double-digit rate, nearly twice as fast as the overall market.
All divisions and regions delivered growth, with Professional Products and Luxe performing particularly strongly, while the SAPMENA-SSA region led the Group’s growth.
Exclusive 50-year licence agreement for Gucci Beauty and fragrance products signed with Kering.
Four new brands launched in Thailand in 2026 – SkinCeuticals, Dr.G, Matrix and Color Wow – further strengthening the skincare and haircare markets.
Nicolas Hieronimus, Chief Executive Officer of L’Oréal Groupe, commented on the results: “L’Oréal delivered an excellent first half of 2026, with growth of +6.5%, maintaining strong momentum and continuing to significantly outperform the global beauty market. Growth was broad-based across all divisions, businesses and regions, driven by two key engines: the seamless execution of our innovation strategy and above-market e-commerce growth, the most dynamic and fastest-growing channel in the industry.
“Our heritage brands continued to perform strongly, while our portfolio was further strengthened through the addition of new brands, including the latest addition from Kering Beauté. Innovation is accelerating, supported by AI, while our markets continue to adapt to rapidly evolving distribution models by winning online through digital excellence and creating elevated brand experiences across offline channels. These strengths position L’Oréal Groupe better than ever to win in beauty and deliver on our ambitions for the full year.”
First-Half Performance by Division[1]
Professional Products: +11.6%
The Professional Products division continued its strong performance, significantly outperforming the salon market. Growth was driven by continued premiumisation in haircare, successful omnichannel strategies and a focus on elevating the salon industry through personalised services.
Premium haircare remained a key growth driver, supported by strong performance from core franchises and new launches including Kérastase Gloss Absolu Crème and L’Oréal Professionnel Keratin Alpha Sleek.
Consumer Products: +4.3%
The division delivered solid growth, with momentum accelerating from the first to the second quarter, led by the outstanding performance of L’Oréal Paris, the world’s leading beauty brand.
All categories contributed to growth, supported by a strong innovation pipeline. Haircare delivered double-digit growth and was the division’s standout category. Makeup benefited from innovations such as L’Oréal Paris Extensionist Mascara and Maybelline New York Serum Lipstick, alongside strong momentum from 3CE.
Skincare continued to benefit from new launches, including L’Oréal Paris Revitalift Filler Glass Skin Liquid Cream. Dr.G also began expanding globally, with launches across China and Southeast Asia, including Thailand.
L’Oréal Luxe: +5.1%
L’Oréal Luxe delivered strong growth, expanding at twice the rate of the global premium beauty market. Fragrance continued to achieve double-digit growth, driven by the outstanding performance of Prada Paradigme, which has emerged as a blockbuster fragrance, as well as the successful expansion of Emporio Armani.
Core franchises also performed strongly, including Yves Saint Laurent Libre, which has become the world’s No. 1 women’s fragrance, alongside MYSLF.
Skincare growth accelerated, driven by the success of Helena Rubinstein Replasty and the promising launch of Lancôme Absolue Longevity M.D., enabling L’Oréal Luxe to capitalise on the growing longevity beauty trend.
Dermatological Beauty: +10.6%
The Dermatological Beauty division delivered strong double-digit growth despite a highly volatile market environment.
Sun care performed particularly well, driven by the successful launch of CeraVe Sun and growing consumer demand for advanced UV protection. La Roche-Posay, CeraVe and SkinCeuticals all achieved double-digit growth.
La Roche-Posay continued to benefit from strong core products such as Cicaplast, alongside successful new launches including Hyalu B5 Suractivated.
SkinCeuticals maintained double-digit growth, supported by strong performance in Northern Asia and the success of A.G.E. Interrupter Ultra Serum, which has been clinically tested to address the needs of consumers using GLP-1 treatments who may experience skin laxity.
Meanwhile, Vichy continued to grow, driven by the strong performance of its Dercos haircare portfolio across markets worldwide.
